Volpara Health Technologies Ltd
ASX:VHT
Volpara Health Technologies Ltd
ASX:VHT
Price:
1.145 AUD
Market Closed
Updated:
May 17, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
8
Current
7.6
Median
2.5
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=8
Enterprise Value
/
279.9m
Revenue
38m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| NZ |
|
Volpara Health Technologies Ltd
ASX:VHT
|
291.3m AUD | 8 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.9B USD | 12.6 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.9 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 3.8 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.2B AUD | 82.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 3.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
5.2B USD | 9.5 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.6B USD | 6.3 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.1B SEK | 27.1 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.9 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
7.8
2-Years Forward
EV/S
6.5
3-Years Forward
EV/S
5.4
You don't have any saved screeners yet
